BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36143120)

  • 1. Exploring the Risk Factors for Poor Survival in Lupus Pericarditis Patients: A Retrospective Cohort Study.
    Chen YF; Hsieh MR; Chang CT; Tsai PH; Fang YF
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36143120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological factors associated with lupus pericarditis: a case-control study.
    Hsieh MR; Chen YF; Chang CT; Yu KH; Fang YF
    Clin Rheumatol; 2023 Apr; 42(4):1061-1067. PubMed ID: 36495382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of adult onset systemic lupus erythematosus in Iran.
    Fatemi A; Matinfar M; Sayedbonakdar Z; Maracy M; Karimzadeh H; Saber M; Smiley A
    Lupus; 2014 Oct; 23(11):1211-6. PubMed ID: 24833666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study.
    Zhao Y; Huang C; You H; Zhao J; Wang Q; Tian X; Zhao Y; Li M; Zeng X
    Lupus; 2022 Jun; 31(7):885-890. PubMed ID: 35411806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features, damage accrual, and survival in patients with familial systemic lupus erythematosus: data from a multi-ethnic, multinational Latin American lupus cohort.
    Quintana R; Pons-Estel GJ; Roberts K; Sacnún M; Serrano R; Nieto R; Conti S; Gervasoni V; Catoggio LJ; Soriano ER; Scolnik M; García MA; Alvarellos A; Saurit V; Berbotto GA; Sato EI; Costallat LTL; Neto EFB; Bonfa E; Xavier RM; de Oliveira E Silva Montandon AC; Molina-Restrepo JF; Iglesias-Gamarra A; Guibert-Toledano M; Reyes-Llerena GA; Massardo L; Neira OJ; Cardiel MH; Barile-Fabris LA; Amigo MC; Silveira LH; Torre IG; Acevedo-Vásquez EM; Ugarte-Gil MF; Alfaro-Lozano JL; Segami MI; Chacón-Díaz R; Esteva-Spinetti MH; Gomez-Puerta JA; Alarcón GS; Pons-Estel BA
    Lupus; 2020 Aug; 29(9):1140-1145. PubMed ID: 32605527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for mortality in systemic lupus erythematosus patients: Analysis of adult and pediatric cohorts in Taiwan.
    Lai CC; Sun YS; Chen WS; Liao HT; Chen MH; Tsai CY; Huang DF; Chou CT; Chang DM
    J Chin Med Assoc; 2022 Nov; 85(11):1044-1050. PubMed ID: 36343272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
    Min HK; Lee JH; Jung SM; Lee J; Kang KY; Kwok SK; Ju JH; Park KS; Park SH
    Korean J Intern Med; 2015 Mar; 30(2):232-41. PubMed ID: 25750566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry.
    Derner O; Kramer A; Hruskova Z; Arici M; Collart F; Finne P; Fuentes Sánchez L; Harambat J; Hemmelder MH; Hommel K; Kerschbaum J; De Meester J; Palsson R; Segelmark M; Skrunes R; Traynor JP; Zurriaga O; Massy ZA; Jager KJ; Stel VS; Tesar V
    Am J Kidney Dis; 2022 May; 79(5):635-645. PubMed ID: 34752912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
    Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
    Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Child-onset systemic lupus erythematosus is associated with a higher incidence of myopericardial manifestations compared to adult-onset disease.
    Chang JC; Xiao R; Mercer-Rosa L; Knight AM; Weiss PF
    Lupus; 2018 Nov; 27(13):2146-2154. PubMed ID: 30318995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China.
    Lin H; Wei JC; Tan CY; Liu YY; Li YH; Li FX; Deng DH; Yan B; Liu Y; Zhao Y
    Clin Rheumatol; 2012 Dec; 31(12):1683-9. PubMed ID: 22983769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
    Fasano S; Margiotta DPE; Pierro L; Navarini L; Riccardi A; Afeltra A; Valentini G
    Clin Rheumatol; 2019 Feb; 38(2):457-463. PubMed ID: 30194649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestation, diagnosis, management, and treatment outcome of pericarditis in patients with systemic lupus erythematosus.
    Buppajamrntham T; Palavutitotai N; Katchamart W
    J Med Assoc Thai; 2014 Dec; 97(12):1234-40. PubMed ID: 25764628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality.
    Fatemi A; Matinfar M; Smiley A
    Clin Rheumatol; 2017 Feb; 36(2):343-350. PubMed ID: 28012055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac manifestations of Han Chinese patients with systemic lupus erythematosus: a retrospective study.
    Jia E; Geng H; Liu Q; Xiao Y; Zhang Y; Xie J; Zhang L; Qiu X; Zhong L; Xiao M; Zhang J
    Ir J Med Sci; 2019 Aug; 188(3):801-806. PubMed ID: 30460452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center.
    Wu G; Jia X; Gao D; Zhao Z
    Clin Rheumatol; 2014 Jul; 33(7):947-53. PubMed ID: 24794488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
    Inês L; Duarte C; Silva RS; Teixeira AS; Fonseca FP; da Silva JA
    Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and variables associated with short and long-term mortality in patients with systemic lupus erythematosus and sepsis admitted in intensive care units.
    Abramovich E; Barrett O; Dreiher J; Novack V; Abu-Shakra M
    Lupus; 2018 Oct; 27(12):1936-1943. PubMed ID: 30185096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and disease related comorbidities in systemic lupus erythematosus: Data from an Egyptian cohort.
    A Mohammed RH; Lotfy Fayed H; Ibrahim Emara N
    Lupus; 2022 Apr; 31(5):628-636. PubMed ID: 35306918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis.
    Merola JF; Bermas B; Lu B; Karlson EW; Massarotti E; Schur PH; Costenbader KH
    Lupus; 2014 Jul; 23(8):778-84. PubMed ID: 24608964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.